MKM timeline
Every MKM batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| MKM-2606-K4013 | Adipotide | 10 Jun 2026 | 2026-Q3 | 2 | 97.48 | 0.88 | 98.13 | +0.65 | |
| MKM-2605-X2575 | BPC-157 | 14 May 2026 | 2026-Q2 | 2 | 98.43 | 0.62 | 98.75 | +0.32 | |
| MKM-2604-A2596 | Gonadorelin | 01 Apr 2026 | 2026-Q2 | 9 | 99.74 | 0.90 | 99.90 | +0.16 | |
| MKM-2603-V2347 | CJC-1295 (no DAC) | 24 Mar 2026 | 2026-Q3 | 1 | 99.28 | n<2 | 99.63 | +0.35 | |
| MKM-2602-X3845 | L-Glutathione (reduced) | 27 Feb 2026 | 2026-Q2 | 1 | 98.59 | n<2 | 98.67 | +0.08 | |
| MKM-2602-M1973 | CJC-1295 with DAC | 16 Feb 2026 | 2026-Q1 | 4 | 99.20 | 1.29 | 99.50 | +0.30 | |
| MKM-2601-Y3343 | Semaglutide | 27 Jan 2026 | 2026-Q2 | 4 | 98.23 | 1.08 | 98.14 | -0.09 | SHARED BULK |
| MKM-2601-L3752 | Tirzepatide | 13 Jan 2026 | 2026-Q2 | 2 | 97.96 | 0.50 | 98.62 | +0.66 | |
| MKM-2512-B2992 | Semax | 25 Dec 2025 | 2026-Q2 | 10 | 98.57 | 0.96 | 99.07 | +0.50 | |
| MKM-2512-Y3111 | CJC-1295 (no DAC) | 22 Dec 2025 | 2026-Q2 | 2 | 97.67 | 0.36 | 98.36 | +0.69 | SHARED BULK |
| MKM-2512-T2524 | Selank | 05 Dec 2025 | 2026-Q1 | 1 | 99.59 | n<2 | 99.90 | +0.31 | |
| MKM-2512-N3913 | Gonadorelin | 01 Dec 2025 | 2026-Q2 | 1 | 99.92 | n<2 | 99.90 | -0.02 | |
| MKM-2511-N2838 | Mazdutide | 20 Nov 2025 | 2026-Q2 | 1 | 98.76 | n<2 | 99.12 | +0.36 | |
| MKM-2511-F2657 | Adipotide | 20 Nov 2025 | 2026-Q1 | 1 | 98.59 | n<2 | 99.21 | +0.62 | |
| MKM-2511-F2902 | L-Glutathione (reduced) | 15 Nov 2025 | 2026-Q2 | 3 | 98.57 | 0.87 | 99.50 | +0.93 | |
| MKM-2510-S2813 | Semaglutide | 11 Oct 2025 | 2026-Q1 | 6 | 98.71 | 1.44 | 99.08 | +0.37 | |
| MKM-2509-T2950 | MK-677 (Ibutamoren mesylate) | 20 Sep 2025 | 2026-Q1 | 1 | 98.42 | n<2 | 99.38 | +0.96 | |
| MKM-2509-B3044 | PT-141 (Bremelanotide) | 01 Sep 2025 | 2025-Q4 | 1 | 99.93 | n<2 | 99.90 | -0.03 | |
| MKM-2508-P3929 | Liraglutide | 29 Aug 2025 | 2025-Q3 | 10 | 98.21 | 1.31 | 98.30 | +0.09 | |
| MKM-2508-R2718 | Semaglutide | 26 Aug 2025 | 2026-Q1 | 9 | 98.97 | 1.39 | 99.31 | +0.34 | |
| MKM-2508-B3505 | Melanotan II | 26 Aug 2025 | 2025-Q4 | 7 | 98.66 | 1.57 | 98.50 | -0.16 | |
| MKM-2508-S3601 | MGF | 25 Aug 2025 | 2025-Q3 | 3 | 98.30 | 0.30 | 98.27 | -0.03 | |
| MKM-2508-K3003 | 5-Amino-1MQ | 10 Aug 2025 | 2025-Q3 | 1 | 98.86 | n<2 | 99.74 | +0.88 | |
| MKM-2507-D3230 | Semaglutide | 24 Jul 2025 | 2025-Q4 | 9 | 98.61 | 0.84 | 99.38 | +0.77 | |
| MKM-2506-D3139 | BPC-157 | 29 Jun 2025 | 2025-Q4 | 13 | 98.92 | 1.06 | 99.10 | +0.18 | |
| MKM-2506-K2643 | GHRP-2 | 23 Jun 2025 | 2025-Q4 | 4 | 99.04 | 0.14 | 99.29 | +0.25 | |
| MKM-2506-T2989 | 5-Amino-1MQ | 02 Jun 2025 | 2025-Q4 | 7 | 99.09 | 0.90 | 99.59 | +0.50 | |
| MKM-2505-J4447 | CJC-1295 (no DAC) | 13 May 2025 | 2025-Q3 | 2 | 99.10 | 0.06 | 98.67 | -0.43 | |
| MKM-2505-M4185 | AOD-9604 | 07 May 2025 | 2025-Q2 | 8 | 98.95 | 1.73 | 98.89 | -0.06 | |
| MKM-2505-X3641 | MK-677 (Ibutamoren mesylate) | 06 May 2025 | 2025-Q4 | 2 | 99.21 | 0.90 | 99.85 | +0.64 | |
| MKM-2504-N3425 | Ipamorelin | 25 Apr 2025 | 2025-Q3 | 8 | 98.82 | 0.97 | 99.50 | +0.68 | |
| MKM-2504-F3495 | Retatrutide | 24 Apr 2025 | 2025-Q2 | 3 | 98.36 | 0.27 | 98.68 | +0.32 | |
| MKM-2504-N3869 | KPV | 21 Apr 2025 | 2025-Q2 | 9 | 99.85 | 0.68 | 99.90 | +0.05 | |
| MKM-2504-K2481 | CJC-1295 (no DAC) | 04 Apr 2025 | 2025-Q3 | 3 | 97.93 | 1.18 | 98.50 | +0.57 | |
| MKM-2503-H2930 | 5-Amino-1MQ | 06 Mar 2025 | 2025-Q3 | 13 | 99.56 | 1.05 | 99.80 | +0.24 | |
| MKM-2502-T2878 | BPC-157 | 03 Feb 2025 | 2025-Q3 | 3 | 99.30 | 0.66 | 99.06 | -0.24 | |
| MKM-2501-U3115 | IGF-1 LR3 | 11 Jan 2025 | 2025-Q2 | 1 | 97.77 | n<2 | 98.33 | +0.56 | |
| MKM-2412-F4188 | TB-500 | 14 Dec 2024 | 2025-Q2 | 3 | 99.39 | 0.54 | 100.00 | +0.61 | |
| MKM-2411-E3058 | Survodutide | 28 Nov 2024 | 2025-Q2 | 8 | 97.90 | 1.18 | 98.39 | +0.49 | |
| MKM-2411-B2994 | Tirzepatide | 19 Nov 2024 | 2025-Q2 | 9 | 97.72 | 1.26 | 97.78 | +0.06 | |
| MKM-2409-W3972 | CJC-1295 with DAC | 13 Sep 2024 | 2025-Q1 | 9 | 98.70 | 1.10 | 99.22 | +0.52 | |
| MKM-2408-L2880 | Enclomiphene citrate | 26 Aug 2024 | 2025-Q1 | 8 | 98.03 | 0.78 | 98.20 | +0.17 | |
| MKM-2408-G3680 | BPC-157 | 08 Aug 2024 | 2024-Q3 | 7 | 99.08 | 1.01 | 99.35 | +0.27 | |
| MKM-2407-Y3393 | Semax | 19 Jul 2024 | 2024-Q3 | 1 | 99.38 | n<2 | 99.90 | +0.52 | |
| MKM-2406-H2712 | PT-141 (Bremelanotide) | 16 Jun 2024 | 2024-Q3 | 10 | 98.33 | 1.15 | 99.22 | +0.89 | |
| MKM-2405-A2532 | GHRP-2 | 31 May 2024 | 2024-Q4 | 4 | 99.15 | 1.13 | 99.37 | +0.22 | |
| MKM-2405-U4415 | Pramlintide | 24 May 2024 | 2024-Q3 | 11 | 98.90 | 1.33 | 99.83 | +0.93 | |
| MKM-2405-C3582 | BPC-157 | 13 May 2024 | 2024-Q4 | 3 | 99.86 | 0.27 | 99.90 | +0.04 | |
| MKM-2404-E2618 | PT-141 (Bremelanotide) | 29 Apr 2024 | 2024-Q3 | 13 | 99.93 | 0.63 | 99.90 | -0.03 | |
| MKM-2403-C3618 | Semaglutide | 26 Mar 2024 | 2024-Q2 | 11 | 98.56 | 1.39 | 98.66 | +0.10 | |
| MKM-2402-N3279 | TB-500 | 02 Feb 2024 | 2024-Q2 | 8 | 99.66 | 0.56 | 99.90 | +0.24 |